Registry of Prospective Clinical Trials - Sixth Report^[*]

• 

^* Space limitation does not allow to publish the full detailed Sixth Report of the Registry of Prospective Clinical Trials, which however can be obtained from the ICTH-office, do H. R. Roberts, Department of Pathology and Medicine, Preclinical Building 228-H, University of South Carolina, Chapel Hill, N. C. 27514, USA

• References

• 1 Verstraete M. Registry of prospective clinical trials. First report. Thrombos Diathes Haemorrh 1975; 33: 655-663
• 2 Verstraete M. Registry of prospective clinical trials. Second report. Thromb Haemostas 1976; 36: 239-250
• 3 Verstraete M. Registry of prospective clinical trials. Third report. Thromb Haemostas 1978; 39: 759-767
• 4 Verstraete M. Registry of prospective clinical trials. Fourth report. Thromb Haemostas 1980; 43: 176-181
• 5 Verstraete M. Registry of prospective clinical trials. Fifth report. Thromb Haemostas 1982; 48: 334-338
• 6 The Sixty Plus Reinfarction Study Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1980 2. 889-894
• 7 The Sixty Plus Reinfarction Study Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1982 1. 64-67
• 8 Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-317
• 9 Schröder R, Biamino G, von Leitner ER, Linderer T, Brüggemann T, Heitz J, Vöhringer HF, Wegscheider K. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983; 67: 536-548
• 10 Kennedy JW, Fritz JK, Ritchie JL. Streptokinase in acute myocardial infarction: Western Washington randomized trial - Protocol and progress report. Am Heart J 1982; 104: 899-911
• 11 Carter AB. Anticoagulant treatment in progressing stroke. Br Med J 1961; 2: 70-73
• 12 Fisher CM. The use of anticoagulants in cerebral thrombosis. Neurology 1958; 8: 311-332
• 13 Fisher CM. Anticoagulant therapy in cerebral thrombosis and cerebral embolism. Neurology 1961; 11: 119-131
• 14 Millikan CH. Anticoagulant therapy in cerebrovascular disease. In Fourth Princeton Conference on CVD. Millikan CH, Siekert RG, Whisnant JP. (eds) p 183 Grune and Stratton; New York: 1965
• 15 Morris JW, Lassen NA. Important points in treatment of progressive stroke. Stroke 1982; 13: 403-404
• 16 Joint Committee for Stroke Resources. XVI. Cerebral ischemia: The role of thrombosis and of antithrombotic therapy. Stroke. 1977 8. 147-176
• 17 Lodder J, van der Lugt PJ M. Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 1983; 14: 42-46
• 18 Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983; 14: 5-14
• 19 Verstraete M, Vermylen J, Verhaeghe RH. Peripheral arterial diseases. Clin Hematol 1981; 10: 669-696
• 20 Verhaeghe R, Verstraete M, Schetz J, Vanhove Ph, Suy R, Vermylen J. Clinical trial of brinase and anticoagulants as a method of treatment for advanced limb ischemia. Eur J Clin Pharmacol 1979; 16: 165-170
• 21 Gruber UF, Saldeen T, Brokop T, Eklöf B, Eriksson I, Goldie I, Gran L, Hohl M, Jonsson T, Kristersson S, Ljungstrom KG, Lund T, Maartman Moe H, Svensjö E, Thomson D, Torhorst J, Trippestad A, Ulstein M. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Br Med J 1980; 1: 69-72
• 22 van de Loo JC V, Kriessmann A, Trübestein G, Knoch K, De Swart CA M, Asbeck F, Marbet GA, Schmitt HE, Sewell AF, Duckert F, Theiss W, Ritz R. Controlled multicenter pilot study of urokinase - heparin and streptokinase in deep vein thrombosis. Thromb Haemostas 1983; 50: 660-663
• 23 EPSIM Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med. 1982 307. 701-708
• 24 Anturan Reinfarction Italian Study Group. Sulphinpyrazone in postmyocardial infarction. Lancet. 1982 1. 237-242
• 25 Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study Stroke 1983; 14: 15-22
• 26 Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study N Engl J Med 1983; 309: 396-403
• 27 Chesebro JH, Fuster V, Elveback LR, Me GoonD, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541